Should You Buy the Dip on Ginkgo Bioworks Stock? [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
specialist isn't necessarily a sign of disaster, and in fact could well be a sign of an opportunity to buy shares at a discount -- assuming those shares can be reasonably expected to rise again in the future. Is that the case with this company, or would it be better to look for opportunities elsewhere? Let's dive in and figure it out. A few core issues will take a long time to address On May 9, Ginkgo reported its first-quarter earnings, and, by some measures, it missed the mark. Revenue from its biofoundry segment was $28 million, 18% less than a year prior. While it succeeded in adding 17 new cell engineering programs within the foundry segment, indicating that there's no lack of other biopharma businesses interested in collaborating with it for a fee, it's still deeply unprofitable Management thus announced a cost-cutting program that aims to reduce expenses by $200 million annually, to be completed before the midpoint of next year. Part of that plan will require slashing l
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Why Ginkgo Bioworks Stock Is Sinking Today [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) had its price target lowered by analysts at BTIG Research from $0.50 to $0.20. They now have a "sell" rating on the stock.MarketBeat
- BioBuilder Launches Skills Training Curriculum to Prepare Students for Careers in Biotechnology [Yahoo! Finance]Yahoo! Finance
- Nvidia's New Sales Booster: The Global Push for Domestic AI Champions [Yahoo! Finance]Yahoo! Finance
- After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 5/9/24 - In-Line
DNA
Sec Filings
- 6/27/24 - Form 144
- 6/26/24 - Form 144
- 6/25/24 - Form PRE
- DNA's page on the SEC website